Jaguar Story

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;'>JH</div>
JAGX -- USA Stock  

USD 2.78  0.48  14.72%

While some baby boomers are getting worried about healthcare space, it is reasonable to break down Jaguar Health against economic and market trends. We are going to address the reasons why we are still confident in anticipation of a recovery. A lot of the latest Jaguar Health price movement was an exact opposite of how the market moved in the last few months. The appearance of strong basic indicators of the company suggests a short-term price swing for investors of Jaguar. The stock experiences an active upward rally.
Published over two weeks ago
View all stories for Jaguar Health | View All Stories
Planning to continue with Jaguar Health (NASDAQ:JAGX) in February?
This firm's average rating is Strong Buy from 1 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Jaguar Health market sentiment investors' perception of the future value of Jaguar. Let us look at a few aspects of Jaguar technical analysis.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Jaguar Health. In general, we focus on analyzing Jaguar Health stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Jaguar Health's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Jaguar Health's intrinsic value. In addition to deriving basic predictive indicators for Jaguar Health, we also check how macroeconomic factors affect Jaguar Health price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Jaguar Health's stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Jaguar Health in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Jaguar Health. Your research has to be compared to or analyzed against Jaguar Health's peers to derive any actionable benefits. When done correctly, Jaguar Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Jaguar Health.

How does Jaguar Stands against Peers?

Analyzing Jaguar Health competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Jaguar Health across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be.
Check out Jaguar Health Competition Details

How Jaguar utilizes its cash?

To perform a cash flow analysis of Jaguar Health, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Jaguar Health is receiving and how much cash it distributes out in a given period. The Jaguar Health cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Jaguar Health Net Cash Flow from Operations is fairly stable at the moment as compared to the past year. Jaguar Health reported Net Cash Flow from Operations of (18.41 Million) in 2020

Acquisition by James Bochnowski of 45486 shares of Jaguar Health subject to Rule 16b-3

Legal trades by Jaguar Health insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Jaguar Health insider trading alert for grant of stock option (right to buy) by James Bochnowski, the corporate stakeholder, on 25th of March 2020. This event was filed by Jaguar Health Inc with SEC on 2020-03-25. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Closer look at Jaguar Health Downside Variance

Jaguar Health has current Downside Variance of 96.73. Downside Variance (or DV) is measured by target semi-variance and is termed downside volatility. It is expressed in percentages and therefore allows for rankings in the same way as variance. One way to view downside volatility is the annualized variance of returns below the target.

Downside Variance is the probability-weighted squared below-target returns. The squaring of the below-target returns has the effect of penalizing failures at an exponential rate. This is consistent with observations made on the behavior of individual decision-making under.

Downside Variance 
 = 
SUM(RET DEV)2 
N(ER) 
 = 
96.73
SUM = Summation notation
RET DEV = Actual returns deviation over selected period
N(ER) = Number of points with returns less than expected return for the period
Let's now compare Jaguar Health Downside Variance to its closest peers:
JAGX
EDIT
DRNA
EQ
DVAX
JAGX96.72976454546723
EDIT20.0
DRNA6.16
EQ40.55
DVAX25.58

Can Jaguar Health build up on the current rise?

Skewness is down to 4.21. It may suggest a possible volatility slide. Jaguar Health is showing large volatility of returns over the selected time horizon. We encourage all investors to investigate this asset further to make sure related market timing strategies are aligned with all the expectations about Jaguar Health implied risk.

The Bottom Line

While some firms within the biotechnology industry are still a little expensive, even after the recent corrections, Jaguar Health may offer a potential longer-term growth to investors. To conclude, as of the 8th of January 2021, our concluding 30 days buy-hold-sell advice on the company is Cautious Hold. We believe Jaguar Health is currently undervalued with high probability of distress for the next two years.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Jaguar Health. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com